Wednesday, January 22, 2020

Afternoon Arrivals
3:00pm – 6:00pm Registration Open / Exhibitor Sign-In and Set-Up
4:00pm – 8:00pm Faculty Slide Review

Thursday, January 23, 2020

6:30am – 10:30am Registration Open
6:45am – 10:30am Exhibits Open
7:00am – 8:00am

Educational Breakfast Symposium (NON-CME)
Important Evidence-Based Changes in the Metastatic Castration-Sensitive Prostate Cancer Treatment Landscape
Speaker: Raoul S. Concepcion, MD

Supported by Astellas Pharma US and Pfizer Oncology

8:00am – 8:15am Visit Exhibits and Refreshments
8:15am – 8:30am IPCU 30 Welcome and Opening Remarks
E. David Crawford, MD – Program Director
8:30am – 10:30am SESSION 1: MEN’S UROLOGIC HEALTH –
Taking Control of Your Prostate Cancer Fate
Moderator: Mark A. Moyad, MD, MPH
8:30am 8:35am Audience Response Questions
Moderator: Mark A. Moyad, MD, MPH
8:35am – 8:50am State of the Art: Nutrition and Prostate Cancer
Mark A. Moyad, MD, MPH
8:50am – 9:00am Ethnic Disparities in Sexual Dysfunction Outcomes
After Prostate Cancer Treatment: Myth or Reality?
Arthur L. Burnett II, MD, MBA
9:00am – 9:10am Counseling of Urinary Health
Ryan P. Terlecki, MD
9:10am – 9:20am Prostate – Most Diseased Organ in the Male Body
Ryan P. Terlecki, MD
9:20am – 9:30am Panel Discussion
9:30am – 9:40am Exercise and Prostate Cancer: Prevention and Bettering Outcomes
in Both Localized and Advanced Prostate Cancer
Arturo Mendoza-Valdes, MD
9:40am – 9:50am Addressing Sarcopenia in the Prostate Cancer Patient
Mark A. Moyad, MD, MPH
9:50am – 10:00am The Role of Genetic Testing in Prostate Cancer
A. Karim Kader, MD, PhD
10:00am – 10:10am An Update in Patient Advocacy Impact
Wendy L. Poage, MHA
10:10am – 10:30am Panel Discussion
10:30am Adjourn
3:30pm – 4:00pm Visit Exhibits and Refreshments
4:00pm – 5:00pm SESSION 2: UROLOGY GROUP PRACTICE
MANAGEMENT – LUGPA Lecture Series
Moderator: R. Jonathan Henderson, MD
4:00pm – 4:05pm Audience Response Questions
Moderator: R. Jonathan Henderson, MD
4:05pm – 4:20pm The Present and Future of LUGPA
Richard G. Harris, MD – President, LUGPA
4:20pm – 4:30pm Sustaining a Research Program in 2020
Evan R. Goldfischer, MD, MBA, CPI, FACS
4:30pm – 4:40pm Advanced Prostate Cancer Clinic: What’s Changing
Richard G. Harris, MD
4:40pm – 4:50pm Telemedicine and Prostate Cancer
Evan R. Goldfischer, MD, MBA, CPI, FACS
4:50pm – 5:00pm Panel Discussion
5:00pm – 5:10pm Facts, Fiction, and Fixes of Physician Burnout
Peter M. Knapp, MD
5:10pm – 5:20pm Prostate Imaging and Biopsy Controversies
Neal D. Shore, MD
5:20pm – 5:30pm Panel Discussion
5:30pm – 6:30pm SESSION 3: THE MICROBIOME AND PROSTATE CANCER –
An Evolving Story
Moderator: J. Curtis Nickel, MD
5:30pm – 5:35pm Audience Response Questions
Moderator: J. Curtis Nickel, MD
5:35pm – 5:50pm Infection and Prostate Cancer: The Old Story
J. Curtis Nickel, MD
5:50pm – 6:05pm Next Generation Sequencing: Writing the New Story
Rick Martin
6:05pm – 6:20pm Microbiome and Prostate Cancer: The New Story
Priya N. Werahera, PhD
6:20pm – 6:30pm Panel Discussion
6:30pm – 7:30pm

Poster Session followed by IPCU/LUGPA Wine and
Cheese Reception – Riverside Ballroom

Moderated by LUGPA Presidents
Richard G. Harris, MD (President)
R. Jonathan Henderson, MD (President Elect)
Raoul S. Concepcion, MD
Peter M. Knapp, MD
Neal D. Shore, MD

Special Guest Speaker: Congressman Neal Dunn, MD

Evening Dinner On Own and Faculty Dinner

Friday, January 24, 2020

6:45am – 11:00am Registration Open
6:45am – 11:00am Exhibits Open
7:00am – 7:45am

Educational Breakfast Symposium (NON-CME)
Biomarkers for Early- and Advanced-Stage Prostate Cancer
Speaker: Robert E. Reiter, MD

Supported by Exact Sciences

7:45am – 8:00am Visit Exhibits and Refreshments
8:00am – 10:30am SESSION 4: GENETICS AND GENOMIC
BIOMARKERS
Moderator: E. David Crawford, MD
8:00am – 8:05am Audience Response Questions
Moderator: E. David Crawford, MD
8:05am – 8:30am State of the Art: A Path Forward for Screening for Prostate Cancer
E. David Crawford, MD
8:30am – 8:45am Case 1– Improving Specificity of PSA Screening:
Serum and Urine Markers – Who Doesn’t Need a Prostate Biopsy?
Daniel W. Lin, MD
8:45am – 9:00am Case 2 – How Molecular Markers and mpMRI Play a Role
R. Jonathan Henderson, MD
9:00am – 9:15am Case 3 – What Role Do Markers Play in Establishing
AS or Definite Care?
Gerald L. Andriole, Jr., MD
9:15am – 9:30am Case 4 – Clinical Implications of Genetics in Prostate Cancer
A. Karim Kader, MD, PhD
9:30am – 9:45am Case 5 – Treating a Patient Denied Coverage Based
on Not Conforming to NCCN Guidelines
James L. Mohler, MD
9:45am – 10:30am Panel Discussion and Take-Home Messages
10:30am Adjourn
3:30pm – 4:00pm

Educational Symposium
Current Considerations and Challenges for Advanced Prostate Cancer
Speaker: Scott B. Sellinger, MD

Supported by Janssen Biotech

4:00pm – 4:15pm Visit Exhibits and Refreshments
4:15pm – 5:00pm

SESSION 5: TRIFECTA OF CARE – Panel Discussion on Integration of Stakeholders in Healthcare
Moderator: Richard G. Harris, MD – President, LUGPA

Audience Response Questions
Moderator: Richard G. Harris, MD

The Academic Experience
Christopher J. Kane, MD

The Group Practice Experience
Edward Cohen, MD

The Kaiser Permanente Experience
Eugene Y. Rhee, MD, MBA

The Small Group Practice Experience
Garrett D. Pohlman, MD

5:00pm – 5:30pm

SESSION 6: UPDATE ON BRACHYTHERAPY FOR PROSTATE CANCER
Moderator: Peter J. Rossi, MD

Audience Response Questions
Moderator: Peter J. Rossi, MD

Panelists:
E. David Crawford, MD
Steven J. Frank, MD
Steven E. Finkelstein, MD, FACRO

5:30pm – 7:05pm SESSION 7: ANDROGEN DEPRIVATION THERAPY
Moderator: Thomas E. Keane, MD
5:30pm – 5:35pm Audience Response Questions
Moderator: Thomas E. Keane, MD
5:35pm – 5:45pm Androgen Deprivation Therapy: A Closer Review of the Role of Anti-Androgens
Thomas E. Keane, MD
5:45pm – 6:05pm

Panel on Androgen Deprivation Therapy:
A Closer Review of the Cardiovascular Risk
Moderator: Thomas E. Keane, MD

Panelists:
Raoul S. Concepcion, MD
E. David Crawford, MD
Lawrence I. Karsh, MD
Peter J. Rossi, MD
Neal D. Shore, MD

6:15pm – 6:45pm

Case 1: Newly Diagnosed Metastatic Disease
E. David Crawford, MD

Discussants: Drs. Andriole, Finkelstein, Hirano, Kane, Keane, Klotz

6:45pm – 7:15pm

Androgen Targeted Therapy Across the Continuum
of Prostate Cancer (NON-CME)
E. David Crawford, MD

Lecture supported by Tolmar Pharmaceuticals

7:15pm – 9:15pm 6th Annual BartlitBeck Dinner, Awards, and IPCU 30th Anniversary Celebration – Gondola Ballroom
With Keynote Speaker Greg Piche, JD, and Entertainment by “The Long Run” (An Eagles Tribute Band)

Saturday, January 25, 2020

6:45am – 10:30am Exhibits Open
7:00am – 7:45am Educational Breakfast Symposium (NON-CME)
ERLEADA® (apalutamide): An Androgen Receptor Inhibitor Indicated For the Treatment of Patients With: Metastatic Castration-Sensitive Prostate Cancer (mCSPC) and Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
Speaker: Jonathan Henderson, MD and Kenneth M. Kernen, MDSupported by Janssen Biotech
7:45am – 8:00am Visit Exhibits and Refreshments
8:00am – 9:00am SESSION 8: ADVANCES IN IMAGING
Moderator: Gerald L. Andriole, Jr., MD
8:00am – 8:05am Audience Response Questions
Moderator: Gerald L. Andriole, Jr., MD
8:05am – 8:15am 29 MHz Micro-Ultrasound for Real-Time Diagnosis of
Prostate Cancer
Priya N. Werahera, PhD
8:15am – 8:25am 29 MHz High Resolution Micro-Ultrasound:
Improving Real-Time Targeting of Prostate Biopsies
Neal D. Shore, MD
8:25am – 8:35am Using High Resolution Micro-Ultrasound for Prostate
Biopsies for Active Surveillance
Laurence Klotz, MD
8:35am – 8:45am MRI-Guided Transurethral Ultrasound Ablation
(TULSA) in Patients with Localized Prostate Cancer:
Results of TACT Pivotal Study
Laurence Klotz, MD
8:45am – 8:55am Panel Discussion
8:55am – 9:05am Multiparametric Magnetic Resonance Imaging for
the Detection of Clinically Significant Prostate
Cancer: What Urologists Need to Know
Part 1: Acquisition
Jelle O. Barentsz, MD, PhD
9:05am – 9:15am Multiparametric Magnetic Resonance Imaging for
the Detection of Clinically Significant Prostate
Cancer: What Urologists Need to Know
Part 2: Interpretation
Jelle O. Barentsz, MD, PhD
9:15am – 9:25am Multiparametric Magnetic Resonance Imaging for
the Detection of Clinically Significant Prostate
Cancer: What Urologists Need to Know
Part 3: Targeted Biopsy
Jelle O. Barentsz, MD, PhD
9:25am – 9:30am Questions and Answers
9:30am – 10:50am SESSION 9: DISEASE STATE CASES/PRESENTATIONS
Moderator: Neal D. Shore, MD
9:35am – 9:50am Audience Response Questions
Moderator: Neal D. Shore, MD
9:35am – 9:50am

Case 1 – Androgen Deprivation Therapy
Neal D. Shore, MD

Discussants: Drs. Concepcion, Cookson, and Keane

9:50am – 10:18am

Case 2 – nmCRPC
R. Jonathan Henderson, MD

Discussants: Drs. Cookson, Harris, Henderson, Hirano, and Klotz

10:18am – 10:20am What Do the NCCN Guidelines Say?
James L. Mohler, MD
10:20am – 10:48am

Case 3 – mCRPC 2
Lawrence I. Karsh, MD

Discussants: Drs. Burnett, Keane, Lin, and Moyad, and Ms. Poage

10:48am – 10:50am What Do the NCCN Guidelines Say?
James L. Mohler, MD
10:50am Adjourn
4:00pm – 4:30pm

Educational Symposium (NON-CME)
Opportunities to Improve Prostate Cancer Management:
The Importance of Testosterone Monitoring
Speaker: Evan R. Goldfischer, MD, MBA, CPI, FACS

Supported by AbbVie

4:30pm – 4:45pm Visit Exhibits and Refreshments
4:45pm – 6:30pm SESSION 10: RAPID FIRE DISEASE STATE
Cases/Presentations
Moderator: Michael S. Cookson, MD, MMHC
4:45pm – 4:50pm Audience Response Questions
Moderator: Michael S. Cookson, MD, MMHC
4:50pm – 5:10pm New Concepts in Cavernous Nerve Localization and
Functional Recovery after Radical Prostatectomy
Arthur L. Burnett II, MD, MBA
5:10pm – 5:25pm PSMA Imaging in Biochemical Recurrence: Does It Help?
Robert E. Reiter, MD
5:25pm – 5:40pm  Novel Approaches to Combining Brachytherapy with Immunotherapy
Steven E. Finkelstein, MD, FACRO
5:40pm – 6:00pm Changing Landscape of mHSPC: New Treatments
for an Old Problem
Michael S. Cookson, MD, MMHC
6:00pm – 6:15pm Panel Discussion and Take-Home Messages
6:15pm – 6:30pm Best Posters of IPCU 30: 3rd-5th Places
6:30pm – 7:30pm Cocktail Reception – Lobby Bar
Evening Dinner on Own

Sunday, January 26, 2020

6:45am – 10:30am Exhibits Open
7:00am – 7:45am

Educational Breakfast Symposium
“Now is the Time for NUBEQA™ (darolutamide)”
Speaker: Lawrence I. Karsh, MD, FACS

Supported by Bayer Healthcare Pharmaceuticals

7:45am – 8:00am Visit Exhibits and Refreshments
8:00am – 9:15am SESSION 11: RAPID FIRE DISEASE STATE
Cases/Presentations
Moderator: E. David Crawford, MD
8:00am – 8:05am Audience Response Questions
Moderator E. David Crawford, MD
8:05am – 8:20am Intracrine Metabolism of Androgens in CRPC:
Development of a Better Abiraterone
James L. Mohler, MD
8:20am – 8:35am Prognostic Factors in Hormone Naïve Metastatic Prostate Cancer
Daisaku Hirano, MD
8:35am – 8:55am Denial of Coverage Due to NCCN Guidelines
James L. Mohler, MD
8:55am – 9:05am Panel Discussion and Take-Home Messages
9:05am – 9:15am Best Posters of IPCU 30: The Top 2
9:15am – 10:30am SESSION 12: PCa CLINICAL TRIAL UPDATES – An Outlook for 2020
Moderator: Daniel P. Petrylak, MD
9:15am – 9:20am Audience Response Questions
Moderator: Daniel P. Petrylak, MD
9:20am – 9:35am Immunotherapy Trials
9:35am – 9:50am Theranostics/Radiopharmaceutical Trials
9:50am – 10:05am Anti-Androgen Trials
10:05am – 10:20am Chemotherapy Trials
10:20am – 10:30am Panel Discussion and Take-Home Messages
10:30am Closing Remarks and Adjourn
E. David Crawford, MD